Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
16.23
+0.19 (1.18%)
At close: Aug 14, 2026, 4:00 PM EDT
16.21
-0.02 (-0.12%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Viatris Employees
Viatris had 30,000 employees as of December 31, 2025. The number of employees decreased by 2,000 or -6.25% compared to the previous year.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$491,243
Profits / Employee
-$13,690
Market Cap
18.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
VTRS News
- 8 days ago - Harrow to acquire global rights to Tyrvaya from Viatris for up to $100M - TheFly
- 8 days ago - Viatris Earnings Call Transcript: Q2 2026 - Transcripts
- 8 days ago - Viatris Slides: Q2 2026 - Filings
- 8 days ago - Viatris Earnings release: Q2 2026 - Filings
- 8 days ago - Viatris Quarterly report: Q2 2026 - Filings
- 8 days ago - Viatris reports Q2 adjusted EPS 69c, consensus 60c - TheFly
- 8 days ago - Viatris raises FY26 adjusted EPS view to $2.45-$2.59 from $2.33-$2.47 - TheFly
- 9 days ago - Viatris Reports Second-Quarter 2026 Financial Results - PRNewsWire